|
WBP5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
<1E-12 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
6.744800E-01 |
| Stage1-vs-Stage3 |
2.721400E-01 |
| Stage1-vs-Stage4 |
2.04630001832129E-09 |
| Stage2-vs-Stage3 |
3.126000E-01 |
| Stage2-vs-Stage4 |
1.004000E-04 |
| Stage3-vs-Stage4 |
1.173680E-04 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.63979940737136E-12 |
| Normal-vs-Asian |
<1E-12 |
| Caucasian-vs-AfricanAmerican |
8.383800E-01 |
| Caucasian-vs-Asian |
8.995400E-01 |
| AfricanAmerican-vs-Asian |
7.911200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
8.452800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
1.52598999999531E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.613600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.366210E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.894600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.536600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.545800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.674010E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.208100E-04 |
| Classical-VS-Follicular |
3.215000E-03 |
| Classical-VS-Other |
4.775600E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
5.14929999972935E-07 |
| Tall-VS-Other |
1.622570E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
9.772000E-01 |
| Follicular-VS-Normal |
<1E-12 |
| Other-VS-Normal |
7.97049999999855E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.62447832963153E-12 |
| N0-vs-N1 |
1.314820E-01 |
|
|
